Industry News
Plan B and the MRFF
The federal government has revised its GP co-payment plan along with the funding mechanism for the proposed Medical Research Future Fund.
[ + ]Imugene completes $3.5m capital raising
Imugene (ASX:IMU) has completed a second placement and SPP to take the total value of its capital raising to $3.5m. Proceeds will be used in part to fund HER-Vaxx trials in gastric cancer.
[ + ]Malaria on the decline
Good news: the number of people dying from malaria has fallen dramatically since 2000, according to the World Malaria Report 2014. [ + ]
New agricultural and environmental sciences precinct
The Australian National University and CSIRO have formed a new collaborative science precinct. [ + ]
Join the Australian pavilion at the China Medical Equipment Fair
AusBiotech seeks your expression of interest to join the Australian delegation to the 73rd China International Medical Equipment Fair (CMEF) in May 2015. It is said to be the Asia-Pacific's largest exhibition, with around 2700 exhibitors and 80,000 visitors.
[ + ]Phosphagenics gets ethics nod for its pain patch trial
Phosphagenics (ASX:POH) has won ethics approval for a proof-of-concept phase II trial of its TPM/Oxycodone patch in neuropathic pain.
[ + ]Orthocell enters bone repair partnership
Orthocell (ASX:OCC) has signed a deal to develop bone repair products combining technology from the company and from Bonesupport.
[ + ]Cell death and skin disease
Abnormal activation of cell death pathways may cause inflammatory skin diseases such as psoriasis. [ + ]
Launch of VivaGel condoms delayed in Japan
Starpharma (ASX:SPL) and partner Okamoto Industries have had to delay the launch of their VivaGel condoms in Japan for at least 3-6 months pending a regulatory classification review.
[ + ]GTG launches $3.1m share purchase plan
Genetic Technologies (ASX:GTG) aims to raise up to $3.1m via a share purchase plan to help commercialise its next-generation breast cancer risk assessment tool BREVAGenplus. [ + ]
Nuclear medicine facility under construction
The first steps in the development of Australia's new nuclear medicine manufacturing facility - the centrepiece of the ANSTO Nuclear Medicine (ANM) Project - are now complete. [ + ]
Expansion underway at WANRI
The Western Australian Neuroscience Research Institute has a new chairman and medical director.
[ + ]Boosting commercial returns from research
AusBiotech has made a submission to the federal government's consultation regarding 'Boosting commercial returns from research', as part of the Industry Innovation and Competitiveness Agenda.
[ + ]Biotron completes recruitment for BIT225 trial
Biotron (ASX:BIT) has enrolled all 60 patients for a Thai phase II trial of BIT225 in HCV genotypes 1 or 3.
[ + ]New brain cancer treatment on trial
Collaborative research carried out for more than a decade will be funnelled into a clinical trial on a treatment for brain cancer. [ + ]
